What amount sold does Sun Mountain Investors, LP report in Form D filings?

The latest linked filings report $85.4M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Sun Mountain Investors, LP's most recent SEC filing?

Sun Mountain Investors, LP's most recent Form D filing was on 2026-08-07.

How many investors does Sun Mountain Investors, LP have?

The most recent Form D filing lists 45 investor(s).

Sun Mountain Investors, LP

CIK: 0001765816·Pooled Investment Fund·BROOKLINE, MA·Limited Partnership

Reported Sold

$85,350,925

Total Filings

Identified Offerings

Last Filed

Aug 7, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pooled Investment Fund industry

SEC EDGAR

Offering filing timeline

Aug 7, 2026Form D/A — Amendment

Reported sold: $85,350,925 · Target: Indefinite

Rule 506(b)·45 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Aug 8, 2025Form D/A — Amendment

Reported sold: $60,655,005 · Target: Indefinite

Rule 506(b)·27 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Aug 9, 2024Form D/A — Amendment

Reported sold: $53,255,000 · Target: Indefinite

Rule 506(b)·26 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Aug 11, 2023Form D/A — Amendment

Reported sold: $43,730,000 · Target: Indefinite

Rule 506(b)·22 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold

Aug 11, 2022Form D/A — Amendment

Reported sold: $38,530,000 · Target: Indefinite

Rule 506(b)·22 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Aug 11, 2021Form D/A — Amendment

Reported sold: $30,325,000 · Target: Indefinite

Rule 506(b)·15 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Aug 11, 2020Form D/A — Amendment

Reported sold: $14,525,000 · Target: Indefinite

Rule 506(b)·12 investors·Section 3(c), Section 3(c)(1)

Jun 8, 2020Form D/A — Amendment

Reported sold: $14,525,000 · Target: Indefinite

Rule 506(b)·12 investors·Section 3(c), Section 3(c)(1)

Jun 12, 2019Form D/A — Amendment

Reported sold: $14,525,000 · Target: Indefinite

Rule 506(b)·12 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Feb 12, 2019Form D — New notice

Reported sold: $5,825,000 · Target: Indefinite

Rule 506(b)·7 investors·Section 3(c), Section 3(c)(1)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

—

Reported commissions across identified offerings

Amendment Rate

90%

Latest reported sold across 1 identified offering

$85,350,925

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Sun Mountain Partners, LLC

Related Person

Appears on 6 filings

Sun Mountain Partners, LLC

Related Person

Appears on 3 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Aug 7, 2026	Amendment	Indefinite	$85,350,925	45
Aug 8, 2025	Amendment	Indefinite	$60,655,005	27
Aug 9, 2024	Amendment	Indefinite	$53,255,000	26
Aug 11, 2023	Amendment	Indefinite	$43,730,000	22
Aug 11, 2022	Amendment	Indefinite	$38,530,000	22
Aug 11, 2021	Amendment	Indefinite	$30,325,000	15
Aug 11, 2020	Amendment	Indefinite	$14,525,000	12
Jun 8, 2020	Amendment	Indefinite	$14,525,000	12
Jun 12, 2019	Amendment	Indefinite	$14,525,000	12
Feb 12, 2019	New	Indefinite	$5,825,000	7

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

AVSF - Integrated Biosciences 2026, LLC

Pooled Investment Fund

Offering target: Indefinite

Filed Nov 5, 2026